All In Biotech

Drug Trial Radar · NCT07133802

Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine in Adults Aged 18-59 Years

Last checked: Nov 20, 2026Latest source record: Aug 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. Randomized with 6,680 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

6,680

Planned (sponsor's estimate)

Start

Aug 2025

Primary completion

Mar 2026

Study completion Jul 2026

Sponsor

Sponsor type
Industry
Collaborators
Hebei Provincial Center for Disease Control and Prevention; Center for Disease Control and Prevention, Fujian; Zhejiang Provincial Center for Disease Control and Prevention
First posted
Aug 21, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 59 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

Conditions

  • Prevention of Influenza

Interventions

  • Placebo GroupBiological

    Each human dose: 0.2 mL

  • Test GroupBiological

    Each human dose is 0.2 mL

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Protective EfficacyTime frame: at 14 days post-vaccination

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.